Small G proteins and their regulators in cellular signalling

Molecular and Cellular Endocrinology

Volumn 353, Issue 1-2, 2012, Pages 10-20

  Csépányi Kömi, Roland ^a   Lévay, Magdolna ^a   Ligeti, Erzsébet ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Endocrine diseases; GTPase activating proteins (GAPs); Guanine nucleotide dissociation inhibitors (GDIs); Guanine nucleotide exchange factors (GEFs); Prenylation; Small G proteins (smg)

Indexed keywords

ARF PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER 4; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; GUANOSINE TRIPHOSPHATE; PROTEIN TYROSINE PHOSPHATASE; RAB PROTEIN; RAN PROTEIN;

CELL MEMBRANE; CELL PROLIFERATION; CELL SHAPE; DOWN REGULATION; ENDOCRINE DISEASE; ENDOCYTOSIS; EXOCYTOSIS; GENE EXPRESSION; GLUCOSE TRANSPORT; HORMONE RELEASE; HUMAN; HUMAN GENOME; HYDROLYSIS; INTERNALIZATION; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SECRETORY VESICLE; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; ENDOCRINE SYSTEM DISEASES; HUMANS; MONOMERIC GTP-BINDING PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84857786579     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.11.005     Document Type: Review

References (152)

1. Adly M.A., Hussein M.R. Immunohistological profile of the Ras homologous B protein (RhoB) in human testes showing normal spermatogenesis, spermatogenic arrest and Sertoli cell only syndrome. Pathol. Oncol. Res. 2010, 16:427-433.
2. Aktories K., Barbieri J.T. Bacterial cytotoxins: targeting eukaryotic switches. Nat. Rev. Microbiol. 2005, 3:397-410.
3. Aligianis I.A., Johnson C.A., Gissen P., Chen D., Hampshire D., Hoffmann K., Maina E.N., Morgan N.V., Tee L., Morton J., Ainsworth J.R., Horn D., Rosser E., Cole T.R., Stolte-Dijkstra I., Fieggen K., Clayton-Smith J., Megarbane A., Shield J.P., Newbury-Ecob R., Dobyns W.B., Graham J.M., Kjaer K.W., Warburg M., Bond J., Trembath R.C., Harris L.W., Takai Y., Mundlos S., Tannahill D., Woods C.G., Maher E.R. Mutations of the catalytic subunit of RAB3GAP cause Warburg Micro syndrome. Nat. Genet. 2005, 37:221-223.
4. Aligianis I.A., Morgan N.V., Mione M., Johnson C.A., Rosser E., Hennekam R.C., Adams G., Trembath R.C., Pilz D.T., Stoodley N., Moore A.T., Wilson S., Maher E.R. Mutation in Rab3 GTPase-activating protein (RAB3GAP) noncatalytic subunit in a kindred with Martsolf syndrome. Am. J. Hum. Genet. 2006, 78:702-707.
5. An Y., Shao Y., Alory C., Matteson J., Sakisaka T., Chen W., Gibbs R.A., Wilson I.A., Balch W.E. Geranylgeranyl switching regulates GDI-Rab GTPase recycling. Structure 2003, 11:347-357.
6. Arany I., Rady P., Evers B.M., Tyring S.K., Townsend C.M. Analysis of multiple molecular changes in human endocrine tumours. Surg. Oncol. 1994, 3:153-159.
7. Asahara, A., Kido, Y., Shogeyama, Y., Matsuda, T., Takeda, A., Inoue, T., 2008. Rac1 regulates glucose-induced insulin secretion through modulation of cytoskeleton organization in beta cells. Diabetes 57 (Suppl. 1).
8. Barres V., Ouellet V., Lafontaine J., Tonin P.N., Provencher D.M., Mes-Masson A.M. An essential role for Ran GTPase in epithelial ovarian cancer cell survival. Mol. Cancer 2010, 9:272-283.
9. Basu T.N., Gutmann D.H., Fletcher J.A., Glover T.W., Collins F.S., Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 1992, 356:713-715.
10. Beg A.A., Sommer J.E., Martin J.H., Scheiffele P. Alpha2-Chimaerin is an essential EphA4 effector in the assembly of neuronal locomotor circuits. Neuron 2007, 55:768-778.
11. Bem D., Yoshimura S., Nunes-Bastos R., Bond F.F., Kurian M.A., Rahman F., Handley M.T., Hadzhiev Y., Masood I., Straatman-Iwanowska A.A., Cullinane A.R., McNeill A., Pasha S.S., Kirby G.A., Foster K., Ahmed Z., Morton J.E., Williams D., Graham J.M., Dobyns W.B., Burglen L., Ainsworth J.R., Gissen P., Muller F., Maher E.R., Barr F.A., Aligianis I.A. Loss-of-Function Mutations in RAB18 Cause Warburg Micro Syndrome. Am. J. Hum. Genet. 2011, 88:499-507.
12. Bernards A. GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila. Biochim. Biophys. Acta 2003, 1603:47-82.
13. Bernards A., Settleman J. GAP control: regulating the regulators of small GTPases. Trends Cell Biol. 2004, 14:377-385.
14. Bollag G., Clapp D.W., Shih S., Adler F., Zhang Y.Y., Thompson P., Lange B.J., Freedman M.H., McCormick F., Jacks T., Shannon K. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat. Genet. 1996, 12:144-148.
15. Borck G., Wunram H., Steiert A., Volk A.E., Korber F., Roters S., Herkenrath P., Wollnik B., Morris-Rosendahl D.J., Kubisch C. A homozygous RAB3GAP2 mutation causes Warburg Micro syndrome. Hum. Genet. 2011, 129:45-50.
16. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Res. 1989, 49:4682-4689.
17. Bos J.L., Rehmann H., Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007, 129:865-877.
18. Bottcher Y., Schleinitz D., Tonjes A., Bluher M., Stumvoll M., Kovacs P. R1467H variant in the rho guanine nucleotide exchange factor 11 (ARHGEF11) is associated with impaired glucose tolerance and type 2 diabetes in German Caucasians. J. Hum. Genet. 2008, 53:365-367.
19. Brandt D.T., Grosse R. Get to grips: steering local actin dynamics with IQGAPs. EMBO Rep. 2007, 8:1019-1023.
20. Bravo-Nuevo A., Sugimoto H., Iyer S., Fallon Z., Lucas J.M., Kazerounian S., Prendergast G.C., Kalluri R., Shapiro N.I., Benjamin L.E. RhoB loss prevents streptozotocin-induced diabetes and ameliorates diabetic complications in mice. Am. J. Pathol. 2011, 178:245-252.
21. Buchsbaum R.J., Connolly B.A., Feig L.A. Regulation of p70 S6 kinase by complex formation between the Rac guanine nucleotide exchange factor (Rac-GEF) Tiam1 and the scaffold spinophilin. J. Biol. Chem. 2003, 278:18833-18841.
22. Buday L., Downward J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 1993, 73:611-620.
23. Buday L., Downward J. Many faces of Ras activation. Biochim. Biophys. Acta 2008, 1786:178-187.
24. Bustos R.I., Forget M.A., Settleman J.E., Hansen S.H. Coordination of Rho and Rac GTPase function via p190B RhoGAP. Curr. Biol. 2008, 18:1606-1611.
25. Cai W.Y., Alexander J.M., Hedley-Whyte E.T., Scheithauer B.W., Jameson J.L., Zervas N.T., Klibanski A. Ras mutations in human prolactinomas and pituitary carcinomas. J. Clin. Endocrinol. Metab. 1994, 78:89-93.
26. Chappell J., Leitner J.W., Solomon S., Golovchenko I., Goalstone M.L., Draznin B. Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence. J. Biol. Chem. 2001, 276:38023-38028.
27. Cho Y.J., Cunnick J.M., Yi S.J., Kaartinen V., Groffen J., Heisterkamp N. Abr and Bcr, two homologous Rac GTPase-activating proteins, control multiple cellular functions of murine macrophages. Mol. Cell. Biol. 2007, 27:899-911.
28. Choi K., Kim Y.B. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J. Intern. Med. 2010, 25:119-129.
29. Chuang T.H., Bohl B.P., Bokoch G.M. Biologically active lipids are regulators of Rac.GDI complexation. J. Biol. Chem. 1993, 268:26206-26211.
30. Colon-Gonzalez F., Leskow F.C., Kazanietz M.G. Identification of an autoinhibitory mechanism that restricts C1 domain-mediated activation of the Rac-GAP alpha2-chimaerin. J. Biol. Chem. 2008, 283:35247-35257.
31. Connolly B.A., Rice J., Feig L.A., Buchsbaum R.J. Tiam1-IRSp53 complex formation directs specificity of rac-mediated actin cytoskeleton regulation. Mol. Cell. Biol. 2005, 25:4602-4614.
32. Couce M.E., Bautista D., Costa J., Carter D. Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms. Diagn. Mol. Pathol. 1999, 8:71-79.
33. Croizet-Berger K., Daumerie C., Couvreur M., Courtoy P.J., van den Hove M.F. The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production. Proc. Natl. Acad. Sci. USA 2002, 99:8277-8282.
34. Csépányi-Kömi, R., Lázár, E., Szabó, J., Wisniewski, E., Sirokmány, G., Geiszt, M., Ligeti, E., 2011. The novel Rac GTPase activating protein ARHGAP25 regulates phagocytosis in neutrophils. Eur. J. Clin. Invest. 41 (Suppl. 1), p. 32.
35. D'Souza-Schorey C., Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol. Cell. Biol. 2006, 7:347-358.
36. Der C.J., Krontiris T.G., Cooper G.M. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc. Natl. Acad. Sci. USA 1982, 79:3637-3640.
37. Demura M., Takeda Y., Yoneda T., Furukawa K., Usukura M., Itoh Y., Mabuchi H. Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Hum. Mutat. 2002, 19:23-29.
38. DerMardirossian C., Rocklin G., Seo J.Y., Bokoch G.M. Phosphorylation of RhoGDI by Src regulates Rho GTPase binding and cytosol-membrane cycling. Mol. Biol. Cell 2006, 17:4760-4768.
39. DerMardirossian C., Schnelzer A., Bokoch G.M. Phosphorylation of RhoGDI by Pak1 mediates dissociation of Rac GTPase. Mol. Cell 2004, 15:117-127.
40. Draznin B., Miles P., Kruszynska Y., Olefsky J., Friedman J., Golovchenko I., Stjernholm R., Wall K., Reitman M., Accili D., Cooksey R., McClain D., Goalstone M. Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia. Endocrinology 2000, 141:1310-1316.
41. Dubois T., Paleotti O., Mironov A.A., Fraisier V., Stradal T.E., De Matteis M.A., Franco M., Chavrier P. Golgi-localized GAP for Cdc42 functions downstream of ARF1 to control Arp2/3 complex and F-actin dynamics. Nat. Cell Biol. 2005, 7:353-364.
42. Eberth A., Lundmark R., Gremer L., Dvorsky R., Koessmeier K.T., McMahon H.T., Ahmadian M.R. A BAR domain-mediated autoinhibitory mechanism for RhoGAPs of the GRAF family. Biochem. J. 2009, 417:371-377.
43. Eguez L., Lee A., Chavez J.A., Miinea C.P., Kane S., Lienhard G.E., McGraw T.E. Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell. Metab. 2005, 2:263-272.
44. Fauchereau F., Herbrand U., Chafey P., Eberth A., Koulakoff A., Vinet M.C., Ahmadian M.R., Chelly J., Billuart P. The RhoGAP activity of OPHN1, a new F-actin-binding protein, is negatively controlled by its amino-terminal domain. Mol. Cell. Neurosci. 2003, 23:574-586.
45. Faure J., Vignais P.V., Dagher M.C. Phosphoinositide-dependent activation of Rho A involves partial opening of the RhoA/Rho-GDI complex. Eur. J. Biochem. 1999, 262:879-889.
46. Fu M., Sabra M.M., Damcott C., Pollin T.I., Ma L., Ott S., Shelton J.C., Shi X., Reinhart L., O'Connell J., Mitchell B.D., Baier L.J., Shuldiner A.R. Evidence that Rho guanine nucleotide exchange factor 11 (ARHGEF11) on 1q21 is a type 2 diabetes susceptibility gene in the Old Order Amish. Diabetes 2007, 56:1363-1368.
47. Fukuhara S., Chikumi H., Gutkind J.S. RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho?. Oncogene 2001, 20:1661-1668.
48. Geiszt M., Dagher M.C., Molnar G., Havasi A., Faure J., Paclet M.H., Morel F., Ligeti E. Characterization of membrane-localized and cytosolic Rac-GTPase-activating proteins in human neutrophil granulocytes: contribution to the regulation of NADPH oxidase. Biochem. J. 2001, 355:851-858.
49. Goalstone M., Kamath V., Kowluru A. Glucose activates prenyltransferases in pancreatic islet beta-cells. Biochem. Biophys. Res. Commun. 2010, 391:895-898.
50. Goalstone M.L., Leitner J.W., Golovchenko I., Stjernholm M.R., Cormont M., Le Marchand-Brustel Y., Draznin B. Insulin promotes phosphorylation and activation of geranylgeranyltransferase II. Studies with geranylgeranylation of rab-3 and rab-4. J. Biol. Chem. 1999, 274:2880-2884.
51. Gohla A., Schultz G., Offermanns S. Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ. Res. 2000, 87:221-227.
52. Govek E.E., Newey S.E., Akerman C.J., Cross J.R., Van der Veken L., Van Aelst L. The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat. Neurosci. 2004, 7:364-372.
53. Grizot S., Faure J., Fieschi F., Vignais P.V., Dagher M.C., Pebay-Peyroula E. Crystal structure of the Rac1-RhoGDI complex involved in nadph oxidase activation. Biochemistry 2001, 40:10007-10013.
54. Hafner M., Schmitz A., Grune I., Srivatsan S.G., Paul B., Kolanus W., Quast T., Kremmer E., Bauer I., Famulok M. Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature 2006, 444:941-944.
55. Han J., Das B., Wei W., Van Aelst L., Mosteller R.D., Khosravi-Far R., Westwick J.K., Der C.J., Broek D. Lck regulates Vav activation of members of the Rho family of GTPases. Mol. Cell. Biol. 1997, 17:1346-1353.
56. Hart M.J., Jiang X., Kozasa T., Roscoe W., Singer W.D., Gilman A.G., Sternweis P.C., Bollag G. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science 1998, 280:2112-2114.
57. Hersch E., Huang J., Grider J.R., Murthy K.S. Gq/G13 signaling by ET-1 in smooth muscle: MYPT1 phosphorylation via ETA and CPI-17 dephosphorylation via ETB. Am. J. Physiol. Cell Physiol. 2004, 287:C1209-C1218.
58. Hoffman G.R., Nassar N., Cerione R.A. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 2000, 100:345-356.
59. Hojlund K., Glintborg D., Andersen N.R., Birk J.B., Treebak J.T., Frosig C., Beck-Nielsen H., Wojtaszewski J.F. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes 2008, 57:357-366.
60. Hrascan R., Pecina-Slaus N., Martic T.N., Colic J.F., Gall-Troselj K., Pavelic K., Karapandza N. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas. J. Neuroendocrinol. 2008, 20:1015-1022.
61. Hu K.Q., Settleman J. Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation. EMBO J. 1997, 16:473-483.
62. Iwasato T., Katoh H., Nishimaru H., Ishikawa Y., Inoue H., Saito Y.M., Ando R., Iwama M., Takahashi R., Negishi M., Itohara S. Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling. Cell 2007, 130:742-753.
63. Jaffe A.B., Aspenstrom P., Hall A. Human CNK1 acts as a scaffold protein, linking Rho and Ras signal transduction pathways. Mol. Cell. Biol. 2004, 24:1736-1746.
64. Jaffe A.B., Hall A., Schmidt A. Association of CNK1 with Rho guanine nucleotide exchange factors controls signaling specificity downstream of Rho. Curr. Biol. 2005, 15:405-412.
65. Jian X., Brown P., Schuck P., Gruschus J.M., Balbo A., Hinshaw J.E., Randazzo P.A. Autoinhibition of Arf GTPase-activating protein activity by the BAR domain in ASAP1. J. Biol. Chem. 2009, 284:1652-1663.
66. Jiang S.Y., Ramachandran S. Comparative and evolutionary analysis of genes encoding small GTPases and their activating proteins in eukaryotic genomes. Physiol. Genomics 2006, 24:235-251.
67. Jiang W., Betson M., Mulloy R., Foster R., Levay M., Ligeti E., Settleman J. P190A RhoGAP is a glycogen synthase kinase-3-beta substrate required for polarized cell migration. J. Biol. Chem. 2008, 283:20978-20988.
68. Jin Q.S., Kim S.H., Piao S.J., Lim H.A., Lee S.Y., Hong S.B., Kim Y.S., Lee H.J., Nam M. R1467H Variants of Rho Guanine Nucleotide Exchange Factor 11 (ARHGEF11) are Associated with Type 2 Diabetes Mellitus in Koreans. Korean Diabetes J. 2010, 34:368-373.
69. Johnson J.L., Erickson J.W., Cerione R.A. New insights into how the Rho guanine nucleotide dissociation inhibitor regulates the interaction of Cdc42 with membranes. J. Biol. Chem. 2009, 284:23860-23871.
70. Karga H.J., Alexander J.M., Hedley-Whyte E.T., Klibanski A., Jameson J.L. Ras mutations in human pituitary tumors. J. Clin. Endocrinol. Metab. 1992, 74:914-919.
71. Karhoff D., Sauer S., Schrader J., Arnold R., Fendrich V., Bartsch D.K., Horsch D. Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target. Neuroendocrinology 2007, 85:45-53.
72. Karlsson H.K., Zierath J.R., Kane S., Krook A., Lienhard G.E., Wallberg-Henriksson H. Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 2005, 54:1692-1697.
73. Kasai K., Ohara-Imaizumi M., Takahashi N., Mizutani S., Zhao S., Kikuta T., Kasai H., Nagamatsu S., Gomi H., Izumi T. Rab27a mediates the tight docking of insulin granules onto the plasma membrane during glucose stimulation. J. Clin. Invest. 2005, 115:388-396.
74. Kasri N., Nakano-Kobayashi A., Malinow R., Li B., Van Aelst L. The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. Genes Dev. 2009, 23:1289-1302.
75. Kawano T., Troiano N., Adams D.J., Wu J.J., Sun B.H., Insogna K. The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice. Endocrinology 2008, 149:4009-4015.
76. Kimmelman A.C., Hezel A.F., Aguirre A.J., Zheng H., Paik J.H., Ying H., Chu G.C., Zhang J.X., Sahin E., Yeo G., Ponugoti A., Nabioullin R., Deroo S., Yang S., Wang X., McGrath J.P., Protopopova M., Ivanova E., Zhang J., Feng B., Tsao M.S., Redston M., Protopopov A., Xiao Y., Futreal P.A., Hahn W.C., Klimstra D.S., Chin L., DePinho R.A. Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc. Natl. Acad. Sci. USA 2008, 105:19372-19377.
77. Kowluru A. Small G proteins in islet beta-cell function. Endocr. Rev. 2010, 31:52-78.
78. Kowluru A., Seavey S.E., Li G., Sorenson R.L., Weinhaus A.J., Nesher R., Rabaglia M.E., Vadakekalam J., Metz S.A. Glucose- and GTP-dependent stimulation of the carboxyl methylation of CDC42 in rodent and human pancreatic islets and pure beta cells. Evidence for an essential role of GTP-binding proteins in nutrient-induced insulin secretion. J. Clin. Invest. 1996, 98:540-555.
79. Krapivinsky G., Krapivinsky L., Manasian Y., Ivanov A., Tyzio R., Pellegrino C., Ben-Ari Y., Clapham D.E., Medina I. The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron 2003, 40:775-784.
80. Krengel U., Schlichting I., Scherer A., Schumann R., Frech M., John J., Kabsch W., Pai E.F., Wittinghofer A. Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. Cell 1990, 62:539-548.
81. Lambert J.M., Lambert Q.T., Reuther G.W., Malliri A., Siderovski D.P., Sondek J., Collard J.G., Der C.J. Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism. Nat. Cell Biol. 2002, 4:621-625.
82. Lampron A., Bourdeau I., Hamet P., Tremblay J., Lacroix A. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. J. Clin. Endocrinol. Metab. 2006, 91:3611-3618.
83. Levay M., Settleman J., Ligeti E. Regulation of the substrate preference of p190RhoGAP by protein kinase C-mediated phosphorylation of a phospholipid binding site. Biochemistry 2009, 48:8615-8623.
84. Ligeti E., Dagher M.C., Hernandez S.E., Koleske A.J., Settleman J. Phospholipids can switch the GTPase substrate preference of a GTPase-activating protein. J. Biol. Chem. 2004, 279:5055-5058.
85. Ligeti E., Settleman J. Regulation of RhoGAP specificity by phospholipids and prenylation. Methods Enzymol. 2006, 406:104-117.
86. Ligeti, E., Welti, S., Scheffzek, K., Inhibition and termination of physiological responses by GTPase activating proteins. Physiol Rev. in press.
87. Liu R.X., Wang W.Q., Ye L., Bi Y.F., Fang H., Cui B., Zhou W.W., Dai M., Zhang J., Li X.Y., Ning G. P21-activated kinase 3 is overexpressed in thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome and participates in cell migration. Endocrine 2010, 38:38-47.
88. Lutz S., Shankaranarayanan A., Coco C., Ridilla M., Nance M.R., Vettel C., Baltus D., Evelyn C.R., Neubig R.R., Wieland T., Tesmer J.J. Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs. Science 2007, 318:1923-1927.
89. Ma L., Hanson R.L., Que L.N., Cali A.M., Fu M., Mack J.L., Infante A.M., Kobes S., Bogardus C., Shuldiner A.R., Baier L.J. Variants in ARHGEF11, a candidate gene for the linkage to type 2 diabetes on chromosome 1q, are nominally associated with insulin resistance and type 2 diabetes in Pima Indians. Diabetes 2007, 56:1454-1459.
90. Malliri A., van der Kammen R.A., Clark K., van der Valk M., Michiels F., Collard J.G. Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 2002, 417:867-871.
91. Minoshima Y., Kawashima T., Hirose K., Tonozuka Y., Kawajiri A., Bao Y.C., Deng X., Tatsuka M., Narumiya S., May W.S., Nosaka T., Semba K., Inoue T., Satoh T., Inagaki M., Kitamura T. Phosphorylation by aurora B converts MgcRacGAP to a RhoGAP during cytokinesis. Dev. Cell 2003, 4:549-560.
92. Missiaglia E., Dalai I., Barbi S., Beghelli S., Falconi M., della Peruta M., Piemonti L., Capurso G., Di Florio A., delle Fave G., Pederzoli P., Croce C.M., Scarpa A. Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J. Clin. Oncol. 2010, 28:245-255.
93. Mitin N., Rossman K.L., Der C.J. Signaling interplay in Ras superfamily function. Curr. Biol. 2005, 15:R563-574.
94. Miura K., Jacques K.M., Stauffer S., Kubosaki A., Zhu K., Hirsch D.S., Resau J., Zheng Y., Randazzo P.A. ARAP1: a point of convergence for Arf and Rho signaling. Mol. Cell 2002, 9:109-119.
95. Molnar G., Dagher M.C., Geiszt M., Settleman J., Ligeti E. Role of prenylation in the interaction of Rho-family small GTPases with GTPase activating proteins. Biochemistry 2001, 40:10542-10549.
96. Moon S.Y., Zheng Y. Rho GTPase-activating proteins in cell regulation. Trends Cell Biol. 2003, 13:13-22.
97. Moskwa P., Paclet M.H., Dagher M.C., Ligeti E. Autoinhibition of p50 Rho GTPase-activating protein (GAP) is released by prenylated small GTPases. J. Biol. Chem. 2005, 280:6716-6720.
98. Mullin B.H., Prince R.L., Dick I.M., Hart D.J., Spector T.D., Dudbridge F., Wilson S.G. Identification of a role for the ARHGEF3 gene in postmenopausal osteoporosis. Am. J. Hum. Genet. 2008, 82:1262-1269.
99. Mullin B.H., Prince R.L., Mamotte C., Spector T.D., Hart D.J., Dudbridge F., Wilson S.G. Further genetic evidence suggesting a role for the RhoGTPase-RhoGEF pathway in osteoporosis. Bone 2009, 45:387-391.
100. Musacchio A., Cantley L.C., Harrison S.C. Crystal structure of the breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85 alpha subunit. Proc. Natl. Acad. Sci. USA 1996, 93:14373-14378.
101. Myers K.R., Casanova J.E. Regulation of actin cytoskeleton dynamics by Arf-family GTPases. Trends Cell Biol. 2008, 18:184-192.
102. Nassar N., Hoffman G.R., Manor D., Clardy J.C., Cerione R.A. Structures of Cdc42 bound to the active and catalytically compromised forms of Cdc42GAP. Nat. Struct. Biol. 1998, 5:1047-1052.
103. Nellore A., Paziana K., Ma C., Tsygankova O.M., Wang Y., Puttaswamy K., Iqbal A.U., Franks S.R., Lv Y., Troxel A.B., Feldman M.D., Meinkoth J.L., Brose M.S. Loss of Rap1GAP in papillary thyroid cancer. J. Clin. Endocrinol. Metab. 2009, 94:1026-1032.
104. Nikiforov, Y.E., 2008. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol. 21 (Suppl. 2), S37-43.
105. Nishioka H., Haraoka J. Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas. Acta Neuropathol. 2005, 109:598-602.
106. Noda Y., Sasaki S. Regulation of aquaporin-2 trafficking and its binding protein complex. Biochim. Biophys. Acta 2006, 1758:1117-1125.
107. Pai E.F., Kabsch W., Krengel U., Holmes K.C., John J., Wittinghofer A. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation. Nature 1989, 341:209-214.
108. Pena V., Hothorn M., Eberth A., Kaschau N., Parret A., Gremer L., Bonneau F., Ahmadian M.R., Scheffzek K. The C2 domain of SynGAP is essential for stimulation of the Rap GTPase reaction. EMBO Rep. 2008, 9:350-355.
109. Rajagopal S., Ji Y., Xu K., Li Y., Wicks K., Liu J., Wong K.W., Herman I.M., Isberg R.R., Buchsbaum R.J. Scaffold proteins IRSp53 and spinophilin regulate localized Rac activation by T-lymphocyte invasion and metastasis protein 1 (TIAM1). J. Biol. Chem. 2010, 285:18060-18071.
110. Rak A., Pylypenko O., Durek T., Watzke A., Kushnir S., Brunsveld L., Waldmann H., Goody R.S., Alexandrov K. Structure of Rab GDP-dissociation inhibitor in complex with prenylated YPT1 GTPase. Science 2003, 302:646-650.
111. Ren J.C., Zhu Q., Lapaglia N., Emanuele N.V., Emanuele M.A. Ethanol-induced alterations in Rab proteins: possible implications for pituitary dysfunction. Alcohol 2005, 35:103-112.
112. Ridley A.J. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 2006, 16:522-529.
113. Rittinger K., Walker P.A., Eccleston J.F., Nurmahomed K., Owen D., Laue E., Gamblin S.J., Smerdon S.J. Crystal structure of a small G protein in complex with the GTPase-activating protein rhoGAP. Nature 1997, 388:693-697.
114. Rogers, M.J., Crockett, J.C., Coxon, F.P., Monkkonen, J., 2010. Biochemical and molecular mechanisms of action of bisphosphonates. Bone. Epub ahead of print.
115. Rolli-Derkinderen M., Toumaniantz G., Pacaud P., Loirand G. RhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor alpha and stimulation of vascular smooth muscle cell migration. Mol. Cell. Biol. 2010, 30:4786-4796.
116. Ross E.M. Coordinating speed and amplitude in G-protein signaling. Curr. Biol. 2008, 18:R777-R783.
117. Sano H., Kane S., Sano E., Miinea C.P., Asara J.M., Lane W.S., Garner C.W., Lienhard G.E. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 2003, 278:14599-14602.
118. Santy L.C., Ravichandran K.S., Casanova J.E. The DOCK180/Elmo complex couples ARNO-mediated Arf6 activation to the downstream activation of Rac1. Curr. Biol. 2005, 15:1749-1754.
119. Satoh T., Endo M., Nakafuku M., Akiyama T., Yamamoto T., Kaziro Y. Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc. Natl. Acad. Sci. USA 1990, 87:7926-7929.
120. Satoh T., Endo M., Nakafuku M., Nakamura S., Kaziro Y. Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. Proc. Natl. Acad. Sci. USA 1990, 87:5993-5997.
121. Scheffzek K., Ahmadian M.R., Kabsch W., Wiesmuller L., Lautwein A., Schmitz F., Wittinghofer A. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 1997, 277:333-338.
122. Scheffzek K., Stephan I., Jensen O.N., Illenberger D., Gierschik P. The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat. Struct. Biol. 2000, 7:122-126.
123. Schoneberg T., Pasel K., von Baehr V., Schulz A., Volk H.D., Gudermann T., Filler G. Compound deletion of the rhoGAP C1 and V2 vasopressin receptor genes in a patient with nephrogenic diabetes insipidus. Hum. Mutat. 1999, 14:163-174.
124. Self A.J., Hall A. Measurement of intrinsic nucleotide exchange and GTP hydrolysis rates. Methods Enzymol. 1995, 256:67-76.
125. Shankaranarayanan A., Boguth C.A., Lutz S., Vettel C., Uhlemann F., Aittaleb M., Wieland T., Tesmer J.J. Galpha q allosterically activates and relieves autoinhibition of p63RhoGEF. Cell. Signal. 2010, 22:1114-1123.
126. Shi L., Fu W.Y., Hung K.W., Porchetta C., Hall C., Fu A.K., Ip N.Y. Alpha2-chimaerin interacts with EphA4 and regulates EphA4-dependent growth cone collapse. Proc. Natl. Acad. Sci. USA 2007, 104:16347-16352.
127. Siliceo M., Merida I. T cell receptor-dependent tyrosine phosphorylation of beta2-chimaerin modulates its Rac-GAP function in T cells. J. Biol. Chem. 2009, 284:11354-11363.
128. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 2009, 10:513-525.
129. Suzuki N., Nakamura S., Mano H., Kozasa T. Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF. Proc. Natl. Acad. Sci. USA 2003, 100:733-738.
130. Tahara S., Sanno N., Teramoto A., Osamura R.Y. Expression of Rab3, a Ras-related GTP-binding protein, in human nontumorous pituitaries and pituitary adenomas. Mod. Pathol. 1999, 12:627-634.
131. Takai Y., Sasaki T., Matozaki T. Small GTP-binding proteins. Physiol. Rev. 2001, 81:153-208.
132. Tcherkezian J., Lamarche-Vane N. Current knowledge of the large RhoGAP family of proteins. Biol. Cell 2007, 99:67-86.
133. Tian X., Gotoh T., Tsuji K., Lo E.H., Huang S., Feig L.A. Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB. EMBO J. 2004, 23:1567-1575.
134. Ueda T., Kikuchi A., Ohga N., Yamamoto J., Takai Y. Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein. J. Biol. Chem. 1990, 265:9373-9380.
135. van den Hove M.F., Croizet-Berger K., Tyteca D., Selvais C., de Diesbach P., Courtoy P.J. Thyrotropin activates guanosine 5'-diphosphate/guanosine 5'-triphosphate exchange on the rate-limiting endocytic catalyst, Rab5a, in human thyrocytes in vivo and in vitro. J. Clin. Endocrinol. Metab. 2007, 92:2803-2810.
136. Vazquez-Martinez R., Martinez-Fuentes A.J., Pulido M.R., Jimenez-Reina L., Quintero A., Leal-Cerro A., Soto A., Webb S.M., Sucunza N., Bartumeus F., Benito-Lopez P., Galvez-Moreno M.A., Castano J.P., Malagon M.M. Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretion. J. Clin. Endocrinol. Metab. 2008, 93:2269-2276.
137. Veluthakal R., Kaur H., Goalstone M., Kowluru A. Dominant-negative alpha-subunit of farnesyl- and geranyltransferase inhibits glucose-stimulated, but not KCl-stimulated, insulin secretion in INS 832/13 cells. Diabetes 2007, 56:204-210.
138. Vetter I.R., Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science 2001, 294:1299-1304.
139. Wang L., Yang L., Burns K., Kuan C.Y., Zheng Y. Cdc42GAP regulates c-Jun N-terminal kinase (JNK)-mediated apoptosis and cell number during mammalian perinatal growth. Proc. Natl. Acad. Sci. USA 2005, 102:13484-13489.
140. Wang Z., Thurmond D.C. Differential phosphorylation of RhoGDI mediates the distinct cycling of Cdc42 and Rac1 to regulate second-phase insulin secretion. J. Biol. Chem. 2010, 285:6186-6197.
141. Wegmeyer H., Egea J., Rabe N., Gezelius H., Filosa A., Enjin A., Varoqueaux F., Deininger K., Schnutgen F., Brose N., Klein R., Kullander K., Betz A. EphA4-dependent axon guidance is mediated by the RacGAP alpha2-chimaerin. Neuron 2007, 55:756-767.
142. Weis K. Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell 2003, 112:441-451.
143. Welch H.C., Coadwell W.J., Ellson C.D., Ferguson G.J., Andrews S.R., Erdjument-Bromage H., Tempst P., Hawkins P.T., Stephens L.R. P-Rex1, a PtdIns(3, 4, 5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 2002, 108:809-821.
144. Welch H.C., Condliffe A.M., Milne L.J., Ferguson G.J., Hill K., Webb L.M., Okkenhaug K., Coadwell W.J., Andrews S.R., Thelen M., Jones G.E., Hawkins P.T., Stephens L.R. P-Rex1 regulates neutrophil function. Curr. Biol. 2005, 15:1867-1873.
145. Wettschureck N., Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 2005, 85:1159-1204.
146. Wu Y.W., Oesterlin L.K., Tan K.T., Waldmann H., Alexandrov K., Goody R.S. Membrane targeting mechanism of Rab GTPases elucidated by semisynthetic protein probes. Nat. Chem. Biol. 2010, 6:534-540.
147. Wuertz C.M., Lorincz A., Vettel C., Thomas M.A., Wieland T., Lutz S. P63RhoGEF-a key mediator of angiotensin II-dependent signaling and processes in vascular smooth muscle cells. FASEB J. 2010, 24:4865-4876.
148. Yaekura K., Julyan R., Wicksteed B.L., Hays L.B., Alarcon C., Sommers S., Poitout V., Baskin D.G., Wang Y., Philipson L.H., Rhodes C.J. Insulin secretory deficiency and glucose intolerance in Rab3A null mice. J. Biol. Chem. 2003, 278:9715-9721.
149. Yamada T., Sakisaka T., Hisata S., Baba T., Takai Y. RA-RhoGAP, Rap-activated Rho GTPase-activating protein implicated in neurite outgrowth through Rho. J. Biol. Chem. 2005, 280:33026-33034.
150. Yeung T., Terebiznik M., Yu L., Silvius J., Abidi W.M., Philips M., Levine T., Kapus A., Grinstein S. Receptor activation alters inner surface potential during phagocytosis. Science 2006, 313:347-351.
151. Zhang C.L., Katoh M., Shibasaki T., Minami K., Sunaga Y., Takahashi H., Yokoi N., Iwasaki M., Miki T., Seino S. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 2009, 325:607-610.
152. Zheng Y. Dbl family guanine nucleotide exchange factors. Trends Biochem. Sci. 2001, 26:724-732.